GENEURO INNOVATION SAS - France 

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 6.846.157 633.296 1
2012 0 3.649.514 124.958 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS GRONINGEN1
ADVANCED PRACTICAL DIAGNOSTICS1
ASSOCIAZIONE FRASCATI SCIENZA1
CROSSLINKS BV1
EDI EXPERIMENTELLE DIAGNOSTISCHE IMMUNOLOGIE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
FOUNDATION BIOLOGICAL PSYCHIATRY1
FUNDACION AGENCIA ARAGONESA PARA LA INVESTIGACION Y EL DESARROLLO1
INSERM TRANSFERT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
KLINICKI BOLNICKI CENTAR RIJEKA1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
PSYNOVA NEUROTECH1
RADIOLOGY MORPHOLOGICAL SOLUTIONS BV1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER1

Constancy:

Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-07-01SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients HERVCOVparticipant6.846.1579
2012-06-01Advanced Immuno-neuro-endocrine Diagnostics in Psychiatry PSYCH-AIDparticipant3.649.51411